Company	Price	Valuation					Profitability					Cash & leverage					Quality				Rating
		P/E	P/B	P/S	EV / EBITDA	DCF upside	Gross margin	Operating margin	Net margin	ROE	ROIC	FCF yield	Debt / equity	Net debt / EBITDA	Interest coverage	Current ratio	Dividend yield	Piotroski (0-9)	Altman Z	Rating score (1-5)
BNTCthis companyBenitec Biopharma Inc.	$9.28	-13.65×	3.52×	0×	-8.75×	-68.5%	0.0%	0.0%	0.0%	-25.7%	-28.8%	-2.7%	0×	3.53×	0×	34×	0.0%	1	43.49	2	C+
GALTGalectin Therapeutics Inc.	$3.29	-8.67×	-2.11×	0×	-16.28×	-156.0%	0.0%	0.0%	0.0%	24.4%	-174.3%	-9.0%	-1.06×	-4.95×	-2.74×	2.42×	0.0%	2	-55.48	2	C
LCTXLineage Cell Therapeutics, Inc.	$1.03	-5.96×	8.63×	26.4×	-5.09×	-251.4%	94.2%	-149.6%	-436.5%	-142.6%	-19.7%	-5.1%	0.05×	0.56×	0×	5.2×	0.0%	3	-3.44	1	C-
NGNENeurogene Inc.	$26.18	-4.86×	1.65×	0×	-3.92×	-83.6%	0.0%	0.0%	0.0%	-34.1%	-37.5%	-18.0%	0.04×	1.08×	-20,641.6×	16.56×	0.0%	1	6.39	2	C
OCGNOcugen, Inc.	$0.96	-5.87×	-33.31×	91.83×	-6.97×	-126.5%	45.9%	-1425.7%	-1537.4%	557.7%	-278.6%	-14.1%	-2.72×	-0.24×	-12.13×	1.06×	0.0%	2	-6.2	2	C
QSIQuantum-Si incorporated	$1.34	-2.16×	0.99×	89.3×	-2.15×	-92.1%	47.3%	-3996.7%	-4160.1%	-46.0%	-43.4%	-44.7%	0.02×	0.19×	0×	7.64×	0.0%	2	4.91	2	C+
Peer median	—	-5.87×	0.99×	26.4×	-5.09×	-126.5%	45.9%	-149.6%	-436.5%	-34.1%	-43.4%	-14.1%	0.02×	0.19×	-2.74×	5.2×	0.0%	2	-3.44	2	—